Search details
1.
Translating RNA sequencing into clinical diagnostics: opportunities and challenges.
Nat Rev Genet
; 17(5): 257-71, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26996076
2.
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.
Int J Cancer
; 145(7): 1889-1901, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-30861105
3.
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Invest New Drugs
; 37(4): 636-645, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30264293
4.
Genomics-Enabled Precision Medicine for Cancer.
Cancer Treat Res
; 178: 137-169, 2019.
Article
in English
| MEDLINE | ID: mdl-31209844
5.
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 366-373, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28314589
6.
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.
Vet Comp Oncol
; 22(1): 30-41, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38053317
7.
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Genome Med
; 16(1): 28, 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347552
8.
XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts.
Anticancer Drugs
; 24(2): 181-8, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23059386
9.
Interrogating the Human Diplome: Computational Methods, Emerging Applications, and Challenges.
Methods Mol Biol
; 2590: 1-30, 2023.
Article
in English
| MEDLINE | ID: mdl-36335489
10.
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Vet Comp Oncol
; 21(3): 482-491, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37248814
11.
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.
Eur Urol Oncol
; 6(4): 447-450, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36609061
12.
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.
Neoplasia
; 43: 100921, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37603953
13.
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.
Sci Transl Med
; 15(678): eabm6863, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36630480
14.
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status.
Mol Cancer
; 11: 75, 2012 Oct 05.
Article
in English
| MEDLINE | ID: mdl-23039341
15.
Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
Int J Gynecol Cancer
; 22(9): 1517-26, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23060048
16.
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Clin Cancer Res
; 28(18): 3965-3978, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35852795
17.
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Cancer Rep (Hoboken)
; 5(11): e1616, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35355452
18.
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Cancer Res
; 81(23): 5818-5832, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34610968
19.
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
PLoS One
; 16(4): e0248097, 2021.
Article
in English
| MEDLINE | ID: mdl-33826614
20.
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.
Mol Cancer Res
; 7(1): 41-54, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19147536